Article detail · 2023
Synthesis, in silico and in vitro evaluation of new 3,5-disubstituted-1,2,4-oxadiazole derivatives as carbonic anhydrase inhibitors and cytotoxic agents
YÖKSİS
OpenAlex
SJR Q2
JCR Q2
Citations 10
Percentile 66.9%
FWCI 0.71
- Year
- 2023
- Type
- article
Data source split
- YÖKSİS YÖKSİS article record
- YÖKSİS venue Journal of Molecular Structure
- Catalog match (ISSN) Journal of Molecular Structure
- OpenAlex OpenAlex enrichment (abstract, citations, topics)
Abstract
Abstract not compiled yet; it will appear after the DergiPark / OpenAlex queue runs.
Topics
Citations
OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.
10 citations
OpenAlex cited_by_count (cache / database)
9 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).
- Imidazole‐hydrazone derivatives: Synthesis, characterization, X‐ray structures and evaluation of anticancer and carbonic anhydrase I–II inhibition properties 2023
- Imidazole‐hydrazone derivatives: Synthesis, characterization, X‐ray structures and evaluation of anticancer and carbonic anhydrase I–II inhibition properties 2023
- Imidazole‐hydrazone derivatives: Synthesis, characterization, X‐ray structures and evaluation of anticancer and carbonic anhydrase I–II inhibition properties 2023
- Imidazole-hydrazone derivatives: Synthesis, characterization, X-ray structures and evaluation of anticancer and carbonic anhydrase I-II inhibition properties 2023
- New hydrazone derivatives: synthesis, characterization, carbonic anhydrase I-II enzyme inhibition, anticancer activity and in silico studies 2025
- New hydrazone derivatives: synthesis, characterization, carbonic anhydrase I-II enzyme inhibition, anticancer activity and in silico studies 2025
- Design and synthesis of piperazine-based 3,5-disubstituted-1,2,4-oxadiazole derivatives as dual AChE and BChE inhibitors: In vitro and in silico studies 2026
- Design and synthesis of piperazine-based 3,5-Disubstituted-1,2,4-oxadiazole derivatives as dual AChE and BChE inhibitors: In vitro and in silico studies 2026
- Design and synthesis of piperazine-based 3,5-disubstituted-1,2,4-oxadia zole derivatives as dual AChE and BChE inhibitors: In vitro and in silico studies 2026